Parliamentary panel asks CSIR to set specific targets to reduce pharmaceutical industry's dependence on imported raw materials

Published On 2023-03-16 10:45 GMT   |   Update On 2023-03-16 10:45 GMT
Advertisement

New Delhi: A parliamentary committee has asked the Council of Scientific and Industrial Research (CSIR) to set short- and long-term targets for reducing the Indian pharmaceutical industry's dependence on imported raw materials from around 80 percent at present to 30-40 percent in the next five years. The Department-related Standing Committee on Science and Technology, Environment, Forests and Climate Change, in its report, said it is fully aware of the current state of huge dependence of the Indian pharmaceutical industry on import of majority of raw materials.

"The committee recommends that specific targets, both short term and long term, should be set for reducing the dependence on imported raw materials from around 80 percent at present to 30 or 40 percent in the next five years," the panel headed by Congress MP Jairam Ramesh said.
To achieve this, the committee said, the proposed mission project should be dovetailed with the initiatives being undertaken in this area by other ministries and departments and the private sector.
It said adequate funds should be earmarked for the purpose so that financial constrains do not hinder the much-needed research work.
"Options should be explored for benefiting from the latest emerging technologies such as artificial intelligence (AI), with the overall objective of achieving the desired outcomes within the shortest possible timeframe," the report stated.
Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News